首頁 > 市場調查報告書 > 醫療設備

體外診斷

全球愛滋病毒/愛滋病診斷市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

市場調查報告書

商品編碼

1305188

全球愛滋病毒/愛滋病診斷市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global HIV/AIDS Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年06月01日 | 出版商:

Value Market Research | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2030年，全球HIV/AIDS診斷市場需求將從2022年的62.2億美元達到近137.5億美元，2023-2030年的複合年成長率為10.42%。

HIV/AIDS診斷是指用於檢測人類免疫缺陷病毒（HIV）的存在和監測獲得性免疫缺陷症候群（AIDS）進展的試驗和方法。這些診斷方法包括各種實驗室檢測和照護端（POC）設備，可檢測HIV抗體或抗原、病毒載量和CD4 T細胞計數。

市場動態：

儘管在HIV/AIDS的預防和治療方面取得了重大進展，但該疾病仍是全球健康領域的一大挑戰。據估計，2019年全球有3800萬愛滋病毒/愛滋病感染者（世衛組織報告）。 HIV/AIDS的高發病率推動了對能夠準確檢測和監測該疾病的診斷產品的需求。隨著中低收入國家醫療保健系統的改善和普及，越來越多的人接受愛滋病毒/愛滋病檢測。這導致了對經濟實惠、準確和易於使用的診斷測試的更大需求。診斷技術的最新進展推動了更靈敏、更特異的HIV/AIDS檢測技術的發展。例如，新的POC設備可以快速、準確地提供結果，從而可以更早地進行診斷和治療。愛滋病毒/愛滋病的自我檢測正變得越來越流行，尤其是在愛滋病毒/愛滋病高發國家。自我檢測允許個人在家中進行自我檢測，而無需醫療服務提供者。由於自我檢測試劑盒準確、價格低廉且易於使用，因此自我檢測試劑盒的需求量不斷增加。各國政府和國際組織正在投資改善愛滋病毒/愛滋病的診斷和治療。這包括資助新診斷技術的研發，以及增加檢測和治療機會的計劃。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構，評估全球範圍內的競爭吸引力。此外，這些工具還對全球愛滋病診斷市場的各個細分市場進行了全面評估。 hiv/愛滋病診斷行業的成長和趨勢為本研究提供了整體方法。

市場細分：

hiv/愛滋病診斷市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按產品分類

試劑盒
儀器

按檢測類型

核酸檢測
快速檢測（POC）
酶聯免疫吸附
其他

按終端用戶分類

醫院
診斷實驗室
學術研究機構
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區當前和未來的HIV/AIDS診斷市場需求。此外，該報告還重點關注了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。愛滋病診斷市場的主要參與者包括Hologic公司、雅培公司、Bio-Rad實驗室公司、F. Hoffmann-La羅氏有限公司、OraSure技術公司、西門子醫療保健有限公司、Chembio診斷公司、丹納赫公司、Becton, Dickinson公司。本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

地區展望銷售分析
銷售分析
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美地區銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區各細分市場銷售分析
- 亞太地區各國銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東及非洲地區銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第十章：HIV/AIDS診斷產品企業競爭格局

愛滋病診斷市場競爭格局
夥伴關係/合作/協議
合併與收購
新產品上市
其他發展

第十一章：公司概況

前10強企業佔有率分析
市場集中率
Hologic Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Abbott
- 公司概況
- 公司收入
- 產品
- 近期發展
Bio-Rad Laboratories Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
F. Hoffmann-La Roche Ltd.
- 公司概況
- 公司收入
- 產品
- 近期發展
OraSure Technologies Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Siemens Healthcare GmbH
- 公司概況
- 公司收入
- 產品
- 近期發展
Chembio Diagnostics Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Danaher Corporation
- 公司概況
- 公司收入
- 產品
- 近期發展
Becton
- 公司概況
- 公司收入
- 產品
- 近期發展
Dickinson and Company
- 公司概況
- 公司收入
- 產品
- 近期發展

*注：在公司概況中，財務細節和近期發展取決於可用性，如果是私營公司，則可能不包括在內。

簡介目錄圖表

Product Code: VMR112110619

The global demand for HIV/AIDS Diagnostics Market is presumed to reach the market size of nearly USD 13.75 BN by 2030 from USD 6.22 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

HIV/AIDS diagnostics refer to the tests and methods used to detect the presence of the human immunodeficiency virus (HIV) and monitor the progression of acquired immunodeficiency syndrome (AIDS). These diagnostics include various laboratory tests and point-of-care (POC) devices that can detect HIV antibodies or antigens, viral load, and CD4 T-cell count.

Market Dynamics:

Despite significant progress in HIV/AIDS prevention and treatment, the disease remains a major global health challenge. There were an estimated 38 million people living with HIV/AIDS worldwide in 2019 (WHO report). This high prevalence of HIV/AIDS is driving the demand for diagnostics that can accurately detect and monitor the disease. As healthcare systems improve and become more accessible in low- and middle-income countries, more people are being tested for HIV/AIDS. This is leading to a greater demand for affordable, accurate, and easy-to-use diagnostic tests. Recent advancements in diagnostic technology have led to the development of more sensitive and specific tests for HIV/AIDS. For example, new POC devices can deliver rapid results with high accuracy, allowing for earlier diagnosis and treatment. Self-testing for HIV/AIDS is becoming more popular, particularly in countries with high HIV/AIDS prevalence. Self-testing allows individuals to test themselves in the privacy of their own home, without the need for a healthcare provider. This has scaled up self-testing kits demand as they are accurate, affordable, and easy to use. Governments and international organizations are investing in initiatives to improve HIV/AIDS diagnosis and treatment. This includes funding for research and development of new diagnostic technologies, as well as programs to increase access to testing and treatment.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hiv/aids diagnostics. The growth and trends of hiv/aids diagnostics industry provide a holistic approach to this study.

Market Segmentation:

This section of the hiv/aids diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Kits And Reagents
Instruments

By Test Type

Nucleic Acid Tests
Rapid Tests (POC)
ELISA
Others

By End-User

Hospitals
Diagnostic Laboratories
Academic And Research Institutes
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the HIV/AIDS Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hiv/aids diagnostics market include Hologic Inc., Abbott, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Siemens Healthcare GmbH, Chembio Diagnostics Inc., Danaher Corporation, Becton, Dickinson and Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HIV/AIDS DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Test Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Kits And Reagents Historic and Forecast Sales by Regions
6.5 Instruments Historic and Forecast Sales by Regions

7 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

7.1 Overview by Test Type
7.2 Historical and Forecast Data
7.3 Analysis by Test Type
7.4 Nucleic Acid Tests Historic and Forecast Sales by Regions
7.5 Rapid Tests (POC) Historic and Forecast Sales by Regions
7.6 ELISA Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
8.6 Academic And Research Institutes Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HIV/AIDS DIAGNOSTICS COMPANIES

10.1. Hiv/Aids Diagnostics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF HIV/AIDS DIAGNOSTICS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Hologic Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Abbott
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Bio-Rad Laboratories Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. F. Hoffmann-La Roche Ltd.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. OraSure Technologies Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Siemens Healthcare GmbH
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Chembio Diagnostics Inc.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Danaher Corporation
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Becton
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Dickinson and Company
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表